Fresenius SE Reduces Stake in Fresenius Medical Care to 20%
Fresenius SE (FSNUF) has announced a reduction in its ownership stake in dialysis provider Fresenius Medical Care (FMS), lowering its holding from approximately 25% to roughly 20%. The move follows the parent company's strategic decision regarding its portfolio management. The announcement triggered an immediate positive reaction in the market, with Fresenius Medical Care shares spiking during premarket trading. Investors are closely monitoring how this divestment affects the capital structure and long-term strategic focus of both healthcare entities.
Tickers: $FMS
Topics: parent company divestment share price movement stake reduction